Sadikuj Jaman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sadikuj Jaman has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Rokibul Hasan Bhuiyan
Department of Biochemistry and Molecular Biology, University of Rajshahi-6205, Bangladesh
3 shared publications - Dipongkar Ray Sobuj
Department of Chemistry and Biochemistry, Lamar University
2 shared publications Maniruzzaman
Department of Pharmacy , Varendra University , Rajshahi , Bangladesh
2 shared publications- Md. Maniruzzaman
Department of Pharmacy, School of Science & Technology, Varendra University, Rajshahi-6204, Bangladesh
2 shared publications - Md. Rakib Rased Rana
Department of Pharmacy, School of Science & Technology, Varendra University, Rajshahi-6204, Bangladesh
2 shared publications - Tamanna Rashid
Department of Chemistry and Biochemistry, Lamar University
2 shared publications
Latest Publications
- Open Access
- 17 September 2026
- Published by E-palli in American Journal of Chemistry and Pharmacy
- Vol. 5 (2) , 31-47
Advances in the Use of Natural Compounds for Cancer Therapy: A Transition from Traditional Approaches to Modern Drug Guidance
Cancer is one of the most serious and leading causes of death worldwide. Many individuals incorporate natural and nutritious foods into their diets which can help prevent cancer and reduce other health risks. Although synthetic drugs are commonly used in cancer treatment and their effectiveness is often limited by drug resistance and adverse side effects. So, physicians and researchers are increasingly focusing on natural products to enhance efficacy of conventional cancer therapies and to minimize associated toxicities. A comprehensive literature search was conducted primarily in google scholar and was supplemented by searches in PubMed, Scopus and Science Direct using relevant keywords. We found that same natural product can inhibit multiple types of cancer and may also be used in combination with pharmaceutical drugs. Important fact is that many people are unaware of anticancer activities of natural products and their potential benefits. It is equally important to highlight limitations of conventional pharmaceutical treatments. So affordable yet valuable natural products should be recognized and further investigated for their therapeutic potential in cancer prevention and treatment. This study aims to discuss different types of cancer and their relationship with natural products as well as anticancer drugs. The main objective is to investigate activity of natural products against various cancer cell types and to compare their effectiveness with that of synthetic drugs used alone. This approach may help bridge traditional and modern treatments and contributing to advancement of cancer therapy in general.
- 17 September 2026
- Published by E-palli in American Journal of Chemistry and Pharmacy
- Vol. 5 (2) , 31-47
Open AccessAdvances in the Use of Natural Compounds for Cancer Therapy: A Transition from Traditional Approaches to Modern Drug Guidance
Cancer is one of the most serious and leading causes of death worldwide. Many individuals incorporate natural and nutritious foods into their diets which can help prevent cancer and reduce other health risks. Although synthetic drugs are commonly used in cancer treatment and their effectiveness is often limited by drug resistance and adverse side effects. So, physicians and researchers are increasingly focusing on natural products to enhance efficacy of conventional cancer therapies and to minimize associated toxicities. A comprehensive literature search was conducted primarily in google scholar and was supplemented by searches in PubMed, Scopus and Science Direct using relevant keywords. We found that same natural product can inhibit multiple types of cancer and may also be used in combination with pharmaceutical drugs. Important fact is that many people are unaware of anticancer activities of natural products and their potential benefits. It is equally important to highlight limitations of conventional pharmaceutical treatments. So affordable yet valuable natural products should be recognized and further investigated for their therapeutic potential in cancer prevention and treatment. This study aims to discuss different types of cancer and their relationship with natural products as well as anticancer drugs. The main objective is to investigate activity of natural products against various cancer cell types and to compare their effectiveness with that of synthetic drugs used alone. This approach may help bridge traditional and modern treatments and contributing to advancement of cancer therapy in general.
- Open Access
- 1 January 2026
- Published by Wiley in International Journal of Breast Cancer
- Vol. 2026 (1) , 2576658
The Roles of MicroRNAs, Oncogenes, and Tumor Suppressor Gene Molecular Subtypes of Breast Cancer: Therapeutic Potential of Pharmaceutical and Natural Products
Background: Breast cancer (BC) is the most common malignancy among women, with 2.3 million new cases and over 670,000 deaths annually. Despite advances in detection and therapy, relapse, metastasis, and resistance remain significant challenges. Tumor suppressor genes (TSGs) regulate abnormal cell division, whereas oncogenes, which arise from proto‐oncogenes, can inhibit TSGs and promote cancer progression. MicroRNAs further influence cellular processes in both normal and malignant states. Pharmaceutical agents such as tamoxifen and paclitaxel have demonstrated efficacy, while natural products, including baicalin and ursolic acid, show promise in modulating oncogenic pathways. Understanding BC subtypes is crucial, as they guide prognosis and enable more precise and personalized treatment strategies. These insights emphasize the complex molecular landscape and evolving approaches to BC therapy. Objective: The review was conducted using a defined set of keywords to search PubMed, Web of Science, Embase, Scopus, Google Scholar, and SciSearch databases covering publications from the inception of each database through August 2, 2025. Key Findings: This review outlines BC subtypes and their molecular features, highlighting TSGs, oncogenes, and miRNAs as therapeutic targets. Both synthetic drugs and natural compounds demonstrate potential applications in advancing BC treatment strategies. Conclusion: BC subtypes, defined by morphology and molecular features, remain vital for targeted therapy advancement. TSGs, oncogenes, and miRNAs play key roles in subtype regulation and require further study for precise detection and treatment. Synthetic drugs and natural compounds show promise as therapeutic agents. However, continued molecular research is essential to improve personalized strategies and overcome relapse, metastasis, and resistance in BC management.
- 1 January 2026
- Published by Wiley in International Journal of Breast Cancer
- Vol. 2026 (1) , 2576658
Open AccessThe Roles of MicroRNAs, Oncogenes, and Tumor Suppressor Gene Molecular Subtypes of Breast Cancer: Therapeutic Potential of Pharmaceutical and Natural Products
Background: Breast cancer (BC) is the most common malignancy among women, with 2.3 million new cases and over 670,000 deaths annually. Despite advances in detection and therapy, relapse, metastasis, and resistance remain significant challenges. Tumor suppressor genes (TSGs) regulate abnormal cell division, whereas oncogenes, which arise from proto‐oncogenes, can inhibit TSGs and promote cancer progression. MicroRNAs further influence cellular processes in both normal and malignant states. Pharmaceutical agents such as tamoxifen and paclitaxel have demonstrated efficacy, while natural products, including baicalin and ursolic acid, show promise in modulating oncogenic pathways. Understanding BC subtypes is crucial, as they guide prognosis and enable more precise and personalized treatment strategies. These insights emphasize the complex molecular landscape and evolving approaches to BC therapy. Objective: The review was conducted using a defined set of keywords to search PubMed, Web of Science, Embase, Scopus, Google Scholar, and SciSearch databases covering publications from the inception of each database through August 2, 2025. Key Findings: This review outlines BC subtypes and their molecular features, highlighting TSGs, oncogenes, and miRNAs as therapeutic targets. Both synthetic drugs and natural compounds demonstrate potential applications in advancing BC treatment strategies. Conclusion: BC subtypes, defined by morphology and molecular features, remain vital for targeted therapy advancement. TSGs, oncogenes, and miRNAs play key roles in subtype regulation and require further study for precise detection and treatment. Synthetic drugs and natural compounds show promise as therapeutic agents. However, continued molecular research is essential to improve personalized strategies and overcome relapse, metastasis, and resistance in BC management.
- 31 December 2025
- Published by Research Synergy Foundation in Journal of Healthcare and Biomedical Science
- Vol. 4 (1)
radioprotector and natural products
Background: Cancer remains one of the most significant global health challenges and radiotherapy continues to be one of the most effective treatment options. However, Patients are also exposed to low doses of ionizing radiation during diagnostic procedures such as computed tomography (CT) and magnetic resonance imaging (MRI). These exposures can induce various cellular and molecular defects in the human body. Therefore, there is an urgent need to develop safer and more reliable radioprotective agents to minimize radiation induced damage. Method: This review was prepared using selected keywords searched across major scientific databases including ScienceDirect, PubMed, Web of Science, MEDLINE, Embase, Scopus, Google Scholar and SCISEARCH covering publications from the inception of each data base up to October 14, 2025. Key findings: This review discusses various plants with reported radioprotective properties and compares the significance of naturally derived and pharmaceutical radioprotective agents. Conclusion: Radioprotective agents offer several advantages in both oncotherapy and diagnostic applications. However, many synthetic radioprotectors are associated with limitations such as high cost, short duration of action, toxicity and adverse effects on the central nervous system. In contrast natural radioprotectors derived from plants have shown the potential to safeguard normal cells from radiation induced radioprotectors derived from plants have shown the potential to safeguard normal cells from radiation induced damage more effectively and safely than their synthetic counterparts. The aim of this review is to identify safer and more effective radioprotective agents for use by oncologists and radiation biologists.
- 31 December 2025
- Published by Research Synergy Foundation in Journal of Healthcare and Biomedical Science
- Vol. 4 (1)
radioprotector and natural products
Background: Cancer remains one of the most significant global health challenges and radiotherapy continues to be one of the most effective treatment options. However, Patients are also exposed to low doses of ionizing radiation during diagnostic procedures such as computed tomography (CT) and magnetic resonance imaging (MRI). These exposures can induce various cellular and molecular defects in the human body. Therefore, there is an urgent need to develop safer and more reliable radioprotective agents to minimize radiation induced damage. Method: This review was prepared using selected keywords searched across major scientific databases including ScienceDirect, PubMed, Web of Science, MEDLINE, Embase, Scopus, Google Scholar and SCISEARCH covering publications from the inception of each data base up to October 14, 2025. Key findings: This review discusses various plants with reported radioprotective properties and compares the significance of naturally derived and pharmaceutical radioprotective agents. Conclusion: Radioprotective agents offer several advantages in both oncotherapy and diagnostic applications. However, many synthetic radioprotectors are associated with limitations such as high cost, short duration of action, toxicity and adverse effects on the central nervous system. In contrast natural radioprotectors derived from plants have shown the potential to safeguard normal cells from radiation induced radioprotectors derived from plants have shown the potential to safeguard normal cells from radiation induced damage more effectively and safely than their synthetic counterparts. The aim of this review is to identify safer and more effective radioprotective agents for use by oncologists and radiation biologists.
- Open Access
- 24 November 2025
- Published by Radinka Jaya Utama Publisher in RADINKA JOURNAL OF HEALTH SCIENCE
- Vol. 3 (2) , 503-528
A Review Potential Radioprotective Mechanism of Molecular Hydrogen via Regulation of Cellular Signaling Pathways
Molecular hydrogen is a biologically significant molecule with diverse applications in the treatment and prevention of diseases in both humans and animals. Exposure to radiation from medical procedures such as CT scans, X-rays, and radiotherapy can disrupt normal cellular functions and cause abnormal cellular behavior. These radiation-induced effects are linked to multiple signaling pathways that contribute to cellular damage. Molecular hydrogen has emerged as a promising therapeutic agent capable of mitigating radiation-related injuries and supporting the recovery of affected cellular pathways. A thorough literature search was carried out using databases including Google Scholar, PubMed, Scopus, and ScienceDirect to obtain detailed information on radiation-related cellular signaling pathways and the possible radioprotective roles of molecular hydrogen. We identified several cellular signaling pathways associated with radiation exposure. Among them are the cell cycle checkpoint pathway, DNA repair pathways, EGFR/tyrosine kinase-mediated pro-survival signaling, Rac1-mediated signaling, ERK1/2 signaling, PI3k/AKT signaling, NF-kB signaling, autophagy signaling, HIF-1α signaling, and YAP signaling pathways. Molecular hydrogen can be administered through various delivery methods and supports the recovery of many of these pathways. It also exhibits multiple beneficial effects in both humans and animals, including antioxidant, anti-apoptotic, anti-inflammatory, and gene regulatory properties. Molecular hydrogen has emerged as one of the most promising radioprotective agents, given that radiation exposure is a major contributor to carcinogenesis and cellular damage. The objective of this review is to elucidate the cellular signaling pathways influenced by radiation and to examine the potential radioprotective mechanisms of molecular hydrogen in mitigating radiation-induced biological effects.
- 24 November 2025
- Published by Radinka Jaya Utama Publisher in RADINKA JOURNAL OF HEALTH SCIENCE
- Vol. 3 (2) , 503-528
Open AccessA Review Potential Radioprotective Mechanism of Molecular Hydrogen via Regulation of Cellular Signaling Pathways
Molecular hydrogen is a biologically significant molecule with diverse applications in the treatment and prevention of diseases in both humans and animals. Exposure to radiation from medical procedures such as CT scans, X-rays, and radiotherapy can disrupt normal cellular functions and cause abnormal cellular behavior. These radiation-induced effects are linked to multiple signaling pathways that contribute to cellular damage. Molecular hydrogen has emerged as a promising therapeutic agent capable of mitigating radiation-related injuries and supporting the recovery of affected cellular pathways. A thorough literature search was carried out using databases including Google Scholar, PubMed, Scopus, and ScienceDirect to obtain detailed information on radiation-related cellular signaling pathways and the possible radioprotective roles of molecular hydrogen. We identified several cellular signaling pathways associated with radiation exposure. Among them are the cell cycle checkpoint pathway, DNA repair pathways, EGFR/tyrosine kinase-mediated pro-survival signaling, Rac1-mediated signaling, ERK1/2 signaling, PI3k/AKT signaling, NF-kB signaling, autophagy signaling, HIF-1α signaling, and YAP signaling pathways. Molecular hydrogen can be administered through various delivery methods and supports the recovery of many of these pathways. It also exhibits multiple beneficial effects in both humans and animals, including antioxidant, anti-apoptotic, anti-inflammatory, and gene regulatory properties. Molecular hydrogen has emerged as one of the most promising radioprotective agents, given that radiation exposure is a major contributor to carcinogenesis and cellular damage. The objective of this review is to elucidate the cellular signaling pathways influenced by radiation and to examine the potential radioprotective mechanisms of molecular hydrogen in mitigating radiation-induced biological effects.
- 10 January 2025
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 209 (3) , 467-485
MicroRNA dynamics, PTEN/PI3K/AKT signaling, and their relationship to breast cancer: prospects for pharmaceuticals and natural product application
Background Globally, Breast Cancer (BC) is the most frequent cancer in women and has a major negative impact on the physical and emotional well-being of its patients as well as one of the most common cancers to be diagnosed. Numerous studies have been published to identify various molecular pathways, including PI3K/AKT/PTEN. Moreover, growing evidence suggests that miRNAs have been found to play a vital role in the growth and carcinogenesis of tumors. Because of their crucial in the development and course of the illness, all other molecular variables, molecular pathways and microRNAs have gained recognition as important therapeutic targets in BC due to growing interest among researchers in utilizing synthetic drugs and natural products to target these signaling pathway with encouraging outcomes in vivo, in vitro and preclinical trials in recent years. Methods We searched PUBMED, Science Direct, google scholar, Embase and Scopus for article published from the inception of each database to May 30, 2024. Results We discussed PI3K/PTEN/AKT signaling pathway and microRNA activities with breast cancer cell line. In addition, this review covered a wide range of potential drug and natural products as targeted therapies that are linked to downregulating ER-α expression and activity, inhibiting proliferation, migration, metastasis and angiogenesis, inducing apoptosis, cell cycle arrest and sensitizing breast cancer cells. Many studies have been conducted, but as of right now, there are not enough articles to fully explain the treatment and research of breast cancer. Conclusions We also need more and more studies on breast cancer from a variety of perspectives. Future scientist will find it easier to consider breast cancer treatment after reading this article presentation. So, the review focuses on our understanding of the roles that microRNA and PI3/PTEN/AKT signaling pathways play in regulating BC. Furthermore, we emphasized the potential therapeutic benefits of newly discovered inhibitors and the use of natural compounds in alone or combinations during preclinical trials.
- 10 January 2025
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 209 (3) , 467-485
MicroRNA dynamics, PTEN/PI3K/AKT signaling, and their relationship to breast cancer: prospects for pharmaceuticals and natural product application
Background Globally, Breast Cancer (BC) is the most frequent cancer in women and has a major negative impact on the physical and emotional well-being of its patients as well as one of the most common cancers to be diagnosed. Numerous studies have been published to identify various molecular pathways, including PI3K/AKT/PTEN. Moreover, growing evidence suggests that miRNAs have been found to play a vital role in the growth and carcinogenesis of tumors. Because of their crucial in the development and course of the illness, all other molecular variables, molecular pathways and microRNAs have gained recognition as important therapeutic targets in BC due to growing interest among researchers in utilizing synthetic drugs and natural products to target these signaling pathway with encouraging outcomes in vivo, in vitro and preclinical trials in recent years. Methods We searched PUBMED, Science Direct, google scholar, Embase and Scopus for article published from the inception of each database to May 30, 2024. Results We discussed PI3K/PTEN/AKT signaling pathway and microRNA activities with breast cancer cell line. In addition, this review covered a wide range of potential drug and natural products as targeted therapies that are linked to downregulating ER-α expression and activity, inhibiting proliferation, migration, metastasis and angiogenesis, inducing apoptosis, cell cycle arrest and sensitizing breast cancer cells. Many studies have been conducted, but as of right now, there are not enough articles to fully explain the treatment and research of breast cancer. Conclusions We also need more and more studies on breast cancer from a variety of perspectives. Future scientist will find it easier to consider breast cancer treatment after reading this article presentation. So, the review focuses on our understanding of the roles that microRNA and PI3/PTEN/AKT signaling pathways play in regulating BC. Furthermore, we emphasized the potential therapeutic benefits of newly discovered inhibitors and the use of natural compounds in alone or combinations during preclinical trials.
- 3 May 2018
- Published by Springer Nature in Breast Cancer
- Vol. 25 (5) , 517-528
Ellagic acid, sulforaphane, and ursolic acid in the prevention and therapy of breast cancer: current evidence and future perspectives
Globally, breast cancer is the most common cancer and the second leading cause of cancer-related death among women. Surgery, chemotherapy, hormonal therapy, and radiotherapy are currently available treatment options for breast cancer therapy. However, chemotherapy, hormonal therapy, and radiotherapy are often associated with side effects and multidrug resistance, recurrence, and lack of treatment in metastasis are the major problems in the treatment of breast cancer. Recently, dietary phytochemicals have emerged as advantageous agents for the prevention and therapy of cancer due to their safe nature. Ellagic acid (EA), sulforaphane (SF), and ursolic acid (UA), which are found in widely consumed fruits and vegetables, have been shown to inhibit breast cancer cell proliferation and to induce apoptosis. This review encompasses the role of EA, SF, and UA in the fight against breast cancer. Both in vitro and in vivo effects of these agents are presented.
- 3 May 2018
- Published by Springer Nature in Breast Cancer
- Vol. 25 (5) , 517-528
Ellagic acid, sulforaphane, and ursolic acid in the prevention and therapy of breast cancer: current evidence and future perspectives
Globally, breast cancer is the most common cancer and the second leading cause of cancer-related death among women. Surgery, chemotherapy, hormonal therapy, and radiotherapy are currently available treatment options for breast cancer therapy. However, chemotherapy, hormonal therapy, and radiotherapy are often associated with side effects and multidrug resistance, recurrence, and lack of treatment in metastasis are the major problems in the treatment of breast cancer. Recently, dietary phytochemicals have emerged as advantageous agents for the prevention and therapy of cancer due to their safe nature. Ellagic acid (EA), sulforaphane (SF), and ursolic acid (UA), which are found in widely consumed fruits and vegetables, have been shown to inhibit breast cancer cell proliferation and to induce apoptosis. This review encompasses the role of EA, SF, and UA in the fight against breast cancer. Both in vitro and in vivo effects of these agents are presented.